Replies to post #89491 on Amarin Corp Plc (AMRN)

[Whalatane]

[color=red][/color]Gabor and Chas

Guess what meds change .
Since ANCHOR was run , don't be surprised if more CAD patients were moved onto Lipitor once it went generic ( Gabor will know the date...:-)

Data clearly shows Lipitor better then Simavastatin .

Suggest you both read up on Dr Christie Ballantynes ( Anchor trial ) views on LDL , HsCrp etc .
For instance

http://www.medscape.com/viewarticle/714693_5

Specifically ...from the link

. Group 4 individuals numerically had the highest average 10-year–predicted CHD risk and the highest MACE rates of the 4 groups, confirming prior analyses from primary prevention trials which showed that the highest incidence of CVD occurred in "high" LDL-C and "high" hs-CRP groups.[14,15] ( thought I'd do a "Gabor "..:-)

So figure this in when you do your calc's with R-IT vs JELIS
thx

Kiwi